Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Akari Therapeutics, Plc (AKTX)

Compare
1.1000
-0.0500
(-4.35%)
At close: 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
17,442
--
23,088
17,214.1360
17,980.9740
Operating Income
-17,442
--
-23,088
-17,214.1360
-17,980.9740
Net Non Operating Interest Income Expense
-106
--
46
10.6000
13.6150
Other Income Expense
-2,609
--
5,294
-220.7010
885.7420
Pretax Income
-20,157
--
-17,748
-17,424.2370
-17,081.6170
Net Income Common Stockholders
-20,157
--
-17,748
-17,424.2370
-17,081.6170
Diluted NI Available to Com Stockholders
-20,157
--
-17,748
-17,424.2370
-17,081.6170
Basic EPS
-2.58
-2.04
-5.40
-8.12
-11.20
Diluted EPS
-2.58
-2.04
-5.40
-8.12
-11.20
Basic Average Shares
8,191.6800
4,894.4900
3,121.7310
2,146.0560
1,122.9330
Diluted Average Shares
8,191.6800
4,894.4900
3,121.7310
2,146.0560
1,579.5190
Total Operating Income as Reported
-21,455
--
-23,088
-17,214.1360
-17,980.9740
Total Expenses
17,442
--
23,088
17,214.1360
17,980.9740
Net Income from Continuing & Discontinued Operation
-20,157
--
-17,748
-17,424.2370
-17,081.6170
Normalized Income
-17,523
--
-23,184
-17,231.0180
-17,989.3660
Interest Income
14
--
46
10.6000
13.6150
Net Interest Income
-106
--
46
10.6000
13.6150
EBIT
-26,835
--
-23,088
-17,214.1360
-17,980.9740
EBITDA
-26,821
--
-23,084
-17,210.0100
-17,972.0670
Reconciled Depreciation
14
--
4
4.1260
8.9070
Net Income from Continuing Operation Net Minority Interest
-20,157
--
-17,748
-17,424.2370
-17,081.6170
Total Unusual Items Excluding Goodwill
-2,634
--
5,436
-193.2190
907.7490
Total Unusual Items
-2,634
--
5,436
-193.2190
907.7490
Normalized EBITDA
-24,187
--
-28,520
-17,016.7910
-18,879.8160
12/31/2020 - 1/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TENX Tenax Therapeutics, Inc.
6.30
-0.63%
 
ATXI Avenue Therapeutics, Inc.
0.2621
-12.63%
 
VTVT vTv Therapeutics Inc.
17.50
+6.71%
 
CTRVP ContraVir Pharmaceuticals, Inc.
 
PULM Pulmatrix, Inc.
6.06
-2.26%
 
GNFT Genfit S.A.
3.4000
-0.29%
 
ARGNF argenx SE
697.42
0.00%
 
EPIX ESSA Pharma Inc.
1.5800
+1.28%
 
BPTH Bio-Path Holdings, Inc.
0.1702
+3.15%
 
SLRN Acelyrin, Inc.
2.7400
+9.16%